Regenerative Medical Technology Group Inc.
RMTG
$0.031
-$0.013-29.55%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.36M | 1.51M | 986.30K | 793.30K | 817.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.36M | 1.51M | 986.30K | 793.30K | 817.00K |
| Cost of Revenue | 420.40K | 530.60K | 239.20K | 266.40K | 248.00K |
| Gross Profit | 943.90K | 980.20K | 747.10K | 526.90K | 569.00K |
| SG&A Expenses | 757.10K | 625.00K | 635.20K | 634.70K | 574.30K |
| Depreciation & Amortization | 51.80K | -27.80K | 88.80K | 83.00K | 76.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.23M | 1.13M | 963.30K | 984.10K | 898.90K |
| Operating Income | 135.00K | 383.00K | 23.10K | -190.80K | -81.80K |
| Income Before Tax | -760.00K | -638.20K | -887.10K | -2.08M | -1.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -760.00K | -638.20K | -887.10K | -2.08M | -1.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -760.00K | -638.20K | -887.10K | -2.08M | -1.96M |
| EBIT | 135.00K | 383.00K | 23.10K | -190.80K | -81.80K |
| EBITDA | 186.80K | 438.10K | 111.90K | -107.80K | -5.30K |
| EPS Basic | -0.06 | -0.05 | -0.07 | -0.17 | -0.16 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.04 | -0.10 | -0.10 |
| EPS Diluted | -0.06 | -0.05 | -0.07 | -0.17 | -0.16 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.04 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.49M | 12.49M |
| Average Diluted Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.49M | 12.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |